Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.

Q4 Medicine

International journal of pharmaceutical compounding Pub Date : 2025-03-01

引用次数: 0

Abstract

In the article "Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration," [Reference: Int J Pharm Compd. 2021; 25 (1): 52-61.] Table 1, row 33 states that the challenge drug was "Total Parenteral Nutrition, Hospira (Lot 87-308-DK)." This challenge drug description should be corrected to "TPN Electrolytes, Hospira (Lot 87-308-DK).

本刊更多论文

勘误-在模拟y位点给药过程中，头孢地罗与选定静脉注射药物的物理相容性。

在文章“模拟y位点给药过程中头孢地罗与选定静脉注射药物的物理相容性”中，[参考文献：Int J Pharm Compd. 2021；25(1): 52-61。表1第33行表明，挑战药物是“全肠外营养，Hospira （Lot 87-308-DK）”。该挑战药物描述应更正为“TPN电解质，Hospira （Lot 87-308-DK）”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of pharmaceutical compounding Medicine-Medicine (all)

CiteScore

0.40

自引率

0.00%

发文量

期刊介绍： The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today"s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.